Business · 08/03/1996
FDA Proposes to Reclassify Nd:YAG Laser for Peripheral Iridotomy from Class III to Class II
The FDA is seeking public comment on a proposal to reclassify the Nd:YAG laser for peripheral iridotomy from a Class III device requiring premarket approval to a Class II device with special controls, following a recommendation from the Ophthalmic Devices Panel
Original source language: Federal Register — Food and Drug AdministrationOpen original release →